Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479905 · ClinicalTrials.gov registry record · NA
The Use of High Flow Nasal Cannula, Standard Face Mask and Standard Nasal Cannula in Morbidly Obese Patients
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT03479905 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 143 participants.
The verdict
NCT03479905, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
It is standard practice in the United States and many parts of world to perform Gastrointestinal endoscopy with the patient under deep intravenous sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The obese population has a higher prevalence of obstructive sleep apnea (OSA), which is characterized by repeated obstruction of the upper airway, and leads to apnea and desaturation. This prospective, randomized study was designed to compare the effectiveness of the high flow nasal cannula, standard nasal cannula and standard face mask in morbidly obese patients with a high risk of sleep apnea, (BMI greater than 40, STOPBANG greater or equal to 5) receiving deep intravenous sedation during colonoscopies. This study will assess which method leads to a lower incidence of intraoperative desaturation events compared to the current standard of care.
Interventions
- DEVICE High Flow Nasal Cannula
- OTHER Salter nasal cannula
- OTHER Face mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479905
The ClinicalTrials.gov registry entry for NCT03479905 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High Flow Nasal Cannula is the first listed.
NCT03479905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479905 about?
NCT03479905 is a clinical study titled "The Use of High Flow Nasal Cannula, Standard Face Mask and Standard Nasal Cannula in Morbidly Obese Patients". It is standard practice in the United States and many parts of world to perform Gastrointestinal endoscopy with the patient under deep intravenous sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The obese pop...
What is the current status of trial NCT03479905?
This trial is currently terminated. It is a NA study. The enrollment target is 143 participants. The study started on 2018-03-05. Estimated completion is 2023-09-20.
What interventions are being tested in trial NCT03479905?
The interventions under investigation include: High Flow Nasal Cannula (DEVICE), Salter nasal cannula (OTHER), Face mask (OTHER).
Who is sponsoring clinical trial NCT03479905?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.